Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
The novel coronavirus disease 2019 (COVID-19) is a global pandemic that continues to sweep across the world, posing an urgent need for effective therapies and prevention of the spread of the severe acute respiratory syndrome related to coronavirus-2 (SARS-CoV-2). A major hypothesis that is currently...
Main Authors: | Vincenzo Lariccia, Simona Magi, Tiziano Serfilippi, Marwa Toujani, Santo Gratteri, Salvatore Amoroso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/4021 |
Similar Items
-
Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)
by: D. E. Karateev, et al.
Published: (2020-09-01) -
Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
by: Si Chen, et al.
Published: (2019-06-01) -
The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection
by: Douglas L. Archer, et al.
Published: (2020-06-01) -
Immunomodulatory Effects of Dietary Polyphenols
by: Hira Shakoor, et al.
Published: (2021-02-01) -
Immunomodulation in sepsis - A case report
by: Rajasekara Chakravarthi Madarasu, et al.
Published: (2021-01-01)